The Cholangiocarcinoma Foundation and the International Cholangiocarcinoma Research Network (ICRN) would be very grateful for your participation in this brief survey regarding the BRAFV600E mutation. The information you provide will be helpful in the research and treatment of patients with cholangiocarcinoma.